These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 16996896)

  • 1. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
    Cooper CB
    Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bronchodilators reduce air-trapping in COPD patients].
    Welte T
    Med Klin (Munich); 2005 Oct; 100 Suppl 1():9-11. PubMed ID: 16422212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
    Ozgur ES; Atis S; Kanik A
    Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.
    Travers J; Laveneziana P; Webb KA; Kesten S; O'Donnell DE
    Respir Med; 2007 Sep; 101(9):2017-24. PubMed ID: 17475459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease.
    Verkindre C; Bart F; Aguilaniu B; Fortin F; Guérin JC; Le Merre C; Iacono P; Huchon G
    Respiration; 2006; 73(4):420-7. PubMed ID: 16484769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
    Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
    O'Donnell DE
    Proc Am Thorac Soc; 2006 Apr; 3(2):180-4. PubMed ID: 16565429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyspnea and activity limitation in COPD: mechanical factors.
    O'Donnell DE; Laveneziana P
    COPD; 2007 Sep; 4(3):225-36. PubMed ID: 17729066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.
    Casaburi R; Maltais F; Porszasz J; Albers F; Deng Q; Iqbal A; Paden HA; O'Donnell DE;
    Ann Am Thorac Soc; 2014 Nov; 11(9):1351-61. PubMed ID: 25289942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation between pulmonary ventilation parameters, exercise tolerance and quality of life in patients with chronic obstructive lung disease].
    Chlumský J; Stĕrbová L; Smolíková L; Matous M; Salajka F
    Vnitr Lek; 2002 Apr; 48(4):320-4. PubMed ID: 12061182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tiotropium as new quality medication in the COPD management].
    Lubiński W; Płusa T
    Pol Merkur Lekarski; 2006 Jan; 20(115):5-7. PubMed ID: 16617725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.
    Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
    Pulm Pharmacol Ther; 2014 Aug; 28(2):158-64. PubMed ID: 24076367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
    Adams SG; Anzueto A; Briggs DD; Menjoge SS; Kesten S
    Respir Med; 2006 Sep; 100(9):1495-503. PubMed ID: 16698259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.
    Berton DC; Reis M; Siqueira AC; Barroco AC; Takara LS; Bravo DM; Andreoni S; Neder JA
    Respir Med; 2010 Sep; 104(9):1288-96. PubMed ID: 20580216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease].
    Jorquera J; Díaz O; Lisboa C
    Rev Med Chil; 2003 Jun; 131(6):605-12. PubMed ID: 12942587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
    O'Donnell DE; Hamilton AL; Webb KA
    J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
    Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
    Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.